Pfizer
More News
-
Explainer-How does AstraZeneca's vaccine compare with Pfizer-BioNTech?
AstraZeneca vaccine’s efficacy in preventing infections was 70.4%, compared with Pfizer/BioNTech's efficacy of 95%
-
UK to roll out Oxford Covid-19 vaccine from Jan 4, Sunday Telegraph says
Govt hopes to give the first dose of Oxford or the Pfizer vaccine to 2 million people over the next two weeks
-
Pfizer, Moderna testing their vaccines against UK coronavirus variant: CNN
Moderna expects immunity from its vaccine to protect against the variants
-
Vatican permits use of Covid-19 vaccines made using aborted foetal tissue
Use of such vaccines permitted as long as there were no alternatives, Vatican tells Roman Catholics
-
WHO vaccine scheme risks failure, leaving poor countries no Covid shots until 2024
Scheme’s promoters say programme is struggling from lack of funds, supply risks and complex contractual arrangements
-
UK has vaccinated 137,897 people so far against Covid, minister says
In the first week of roll-out of the shot developed by Pfizer and BioNTech says minister
-
US poised to hit 16 million Covid cases within days even as vaccine begins roll-out
First batch of shots is expected to aim health care workers and residents and staff of long-term care facilities
-
US FDA authorizes Pfizer Covid-19 vaccine for emergency use
Healthcare workers and elderly people in long-term care facilities are expected to be the main recipients
-
Analysis: World watches as first-mover Britain probes adverse reactions to Pfizer vaccine
Officials from around the world keen to get information about the two reported cases of anaphylaxis
-
Moderna begins study of Covid-19 vaccine in adolescents
Pfizer is also studying its vaccine candidate in participants as young as 12
